Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer.
about
Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials.Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet.PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study.
P2860
Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Association Between Early PSA ...... ion Resistant Prostate Cancer.
@en
type
label
Association Between Early PSA ...... ion Resistant Prostate Cancer.
@en
prefLabel
Association Between Early PSA ...... ion Resistant Prostate Cancer.
@en
P2093
P2860
P50
P1476
Association Between Early PSA ...... ion Resistant Prostate Cancer.
@en
P2093
Catherine Hanna
Cristian Lolli
Francesca Maines
Helen Joyce
Lisa Derosa
Paolo Fabbri
Robert J Jones
Sunnya Zarif
Tony Elliott
Ugo De Giorgi
P2860
P2888
P304
P356
10.1007/S40291-016-0196-1
P577
2016-03-28T00:00:00Z